Related Experiment Videos
Treatment options in lymph node-positive prostate cancer
Gregory P Swanson1, Ian M Thompson, Joseph Basler
1Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA. gswanson@ctrc.net
Cancer
|May 16, 2006
Summary
The incidence of lymph node-positive prostate cancer has decreased, but treatment options like androgen ablation, surgery, and radiation remain viable for patients, with no single approach proving superior.
Area of Science:
- Oncology
- Urology
Background:
- Improved awareness and screening have led to a significant decline in lymph node-positive prostate cancer incidence over 50 years.
- Key risk factors for positive lymph nodes include cancer stage, prostate-specific antigen levels, and tumor grade.
Purpose of the Study:
- To review the current treatment landscape for lymph node-positive prostate cancer.
- To discuss the prognostic significance of lymph node involvement and related factors.
Main Methods:
- Review of existing literature on prostate cancer treatment modalities.
- Analysis of prognostic factors influencing outcomes in lymph node-positive cases.
Main Results:
- Despite declining incidence, a significant number of men still present with lymph node-positive prostate cancer.
- Established treatments include androgen ablation, surgery, and radiation, often used in combination.
- Chemotherapy has been explored, but no single treatment has demonstrated superiority.
Conclusions:
- Several effective treatment alternatives exist for lymph node-positive prostate cancer.
- Long-term survival is achievable for many patients, indicating the effectiveness of current management strategies.